doi: 10.1007/s00066-025-02430-y.
Online ahead of print.
[Less is more: dose de-escalation in early anal cancer-Clinical and functional aspects of quality of life from the PLATO-ACT4 trial]
[Article in
German]
Affiliations
- PMID: 40691295
- DOI: 10.1007/s00066-025-02430-y
Item in Clipboard
[Less is more: dose de-escalation in early anal cancer-Clinical and functional aspects of quality of life from the PLATO-ACT4 trial]
[Article in
German]
Strahlenther Onkol.
.
No abstract available
Conflict of interest statement
Interessenkonflikt: L. Völler, E. Fokas, C. Rödel und D. Martin geben an, dass kein Interessenkonflikt besteht.
Similar articles
-
Use of endoanal ultrasound for reducing the risk of complications related to anal sphincter injury after vaginal birth.Cochrane Database Syst Rev. 2015 Oct 29;2015(10):CD010826. doi: 10.1002/14651858.CD010826.pub2. Cochrane Database Syst Rev. 2015. PMID: 26513224 Free PMC article.
-
Positron emission tomography-adapted therapy for first-line treatment in adults with Hodgkin lymphoma.Cochrane Database Syst Rev. 2025 Mar 26;3(3):CD010533. doi: 10.1002/14651858.CD010533.pub3. Cochrane Database Syst Rev. 2025. PMID: 40135712
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
-
De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock.Cochrane Database Syst Rev. 2010 Dec 8;(12):CD007934. doi: 10.1002/14651858.CD007934.pub2. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2013 Mar 28;(3):CD007934. doi: 10.1002/14651858.CD007934.pub3. PMID: 21154391 Updated.
References
Literatur
-
- Gilbert A, Adams R, Webster J et al (2025) Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trial. Lancet Oncol. https://doi.org/10.1016/S1470-2045(25)00213-X - DOI - PubMed
-
- James RD, Glynne-Jones R, Meadows HM et al (2013) Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial. Lancet Oncol 14(6):516–524 - PubMed
-
- Gunderson LL, Winter KA, Ajani JA et al (2012) Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin. J Clin Oncol 30(35):4344–4351 - PubMed - PMC
-
- Bartelink H, Roelofsen F, Eschwege F et al (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15:2040–2049 - PubMed
-
- Pan YB, Maeda Y, Wilson A et al (2018) Late gastrointestinal toxicity after radiotherapy for anal cancer: a systematic literature review. Acta Oncol 57(11):1427–1437 - PubMed
LinkOut - more resources
Full Text Sources
